| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2015 | DHR Danaher Corp /de/ | Graham Jonathan P | Senior VP &GC | Sell | 30,232 | $86.89 | $2,626,850.22 | -18.1% | |
| May 19, 2015 | IQV Iqvia Holdings Inc. | Tpg Advisors V, Inc. | 10% Owner, May Be Deemed 10% Owner (3)(4) | Sell | 2,251,719 | $64.85 | $146,023,977.15 | -20.1% | |
| May 19, 2015 | PRPH Prophase Labs, Inc. | Karkus Ted William | CEO &Chairman | Buy | 210,000 | $1.35 | $283,395.04 | +4.6% | |
| May 18, 2015 | WST West Pharmaceutical Services Inc | Flynn Karen | President, Pharma Pckg Systems | Sell | 1,909 | $55.00 | $104,995.00 | -7.2% | |
| May 18, 2015 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 9,800 | $326.25 | $3,197,288.08 | -46.7% | |
| May 15, 2015 | CRL Charles River Laboratories International, Inc. | Ackerman Thomas F | Corporate Executive VP &CFO | Sell | 3,900 | $70.51 | $274,974.20 | -0.1% | |
| May 15, 2015 | CRL Charles River Laboratories International, Inc. | Ackerman Thomas F | Corporate Executive VP &CFO | Sell | 1,100 | $71.06 | $78,168.00 | -0.1% | |
| May 15, 2015 | TMO Thermo Fisher Scientific Inc. | Malus Alan J | Executive Vice President | Sell | 40,350 | $130.09 | $5,249,046.72 | -25.8% | |
| May 15, 2015 | DHR Danaher Corp /de/ | Graham Jonathan P | Senior VP &GC | Sell | 185,620 | $87.73 | $16,285,009.36 | -63.1% | |
| May 15, 2015 | WST West Pharmaceutical Services Inc | Morel Donald E Jr | Chair Of The Board &CEO | Sell | 20,000 | $54.29 | $1,085,709.00 | -1.2% | |
| May 14, 2015 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc56 | Head Of Eur &Na Market Orgs. | Sell | 16,000 | $325.01 | $5,200,160.00 | -58.3% | |
| May 14, 2015 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 10,000 | $324.88 | $3,248,755.00 | -47.2% | |
| May 14, 2015 | MTD Mettler Toledo International Inc/ | Donnelly William P | Executive Vice President | Sell | 3,782 | $324.20 | $1,226,129.83 | -55.8% | |
| May 12, 2015 | MTD Mettler Toledo International Inc/ | Filliol Oliver A71 | President And CEO | Sell | 25,000 | $323.72 | $8,092,952.48 | -20.4% | |
| May 12, 2015 | MTD Mettler Toledo International Inc/ | Donnelly William P | Executive Vice President | Sell | 13,718 | $325.24 | $4,461,693.50 | -77.4% | |
| May 11, 2015 | MTD Mettler Toledo International Inc/ | Salice Thomas P65 | Director | Sell | 3,000 | $325.00 | $975,000.00 | -7.2% | |
| May 7, 2015 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 1,360 | $70.21 | $95,486.80 | -0.7% | |
| May 1, 2015 | WAT Waters Corp /de/ | Salice Thomas P65 | Director | Sell | 4,000 | $126.76 | $507,040.00 | -26.3% | |
| May 1, 2015 | WAT Waters Corp /de/ | Glimcher Laurie H M.D. | Director | Sell | 4,000 | $126.40 | $505,600.00 | -43.5% | |
| May 1, 2015 | CRL Charles River Laboratories International, Inc. | Chubb Stephen D | Director | Sell | 2,000 | $69.80 | $139,595.20 | -11.4% | |
| Apr 24, 2015 | DHR Danaher Corp /de/ | Comas Daniel L | EVP &CFO | Sell | 25,000 | $83.50 | $2,087,385.60 | -11.0% | |
| Apr 24, 2015 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 43,945 | $83.81 | $3,683,075.82 | -14.9% | |
| Apr 24, 2015 | DHR Danaher Corp /de/ | Daniel William K | EVP | Sell | 58,400 | $83.33 | $4,866,312.80 | -20.5% | |
| Apr 23, 2015 | TMO Thermo Fisher Scientific Inc. | Lynch Thomas J | Director | Sell | 5,000 | $130.15 | $650,750.00 | -33.4% | |
| Apr 21, 2015 | TMO Thermo Fisher Scientific Inc. | Hoogasian Seth H | Sr. VP, Gen. Counsel &Sec. | Sell | 13,256 | $135.00 | $1,789,560.00 | -26.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.